These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 11697954)

  • 1. Chemoenzymatic synthesis of sialylated glycopeptides derived from mucins and T-cell stimulating peptides.
    George SK; Schwientek T; Holm B; Reis CA; Clausen H; Kihlberg J
    J Am Chem Soc; 2001 Nov; 123(45):11117-25. PubMed ID: 11697954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient chemoenzymatic synthesis of O-linked sialyl oligosaccharides.
    Blixt O; Allin K; Pereira L; Datta A; Paulson JC
    J Am Chem Soc; 2002 May; 124(20):5739-46. PubMed ID: 12010048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen.
    Marcos NT; Pinho S; Grandela C; Cruz A; Samyn-Petit B; Harduin-Lepers A; Almeida R; Silva F; Morais V; Costa J; Kihlberg J; Clausen H; Reis CA
    Cancer Res; 2004 Oct; 64(19):7050-7. PubMed ID: 15466199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression.
    Brockhausen I; Yang J; Lehotay M; Ogata S; Itzkowitz S
    Biol Chem; 2001 Feb; 382(2):219-32. PubMed ID: 11308020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of O-glycan biosynthesis in human colon cancer tissues.
    Yang JM; Byrd JC; Siddiki BB; Chung YS; Okuno M; Sowa M; Kim YS; Matta KL; Brockhausen I
    Glycobiology; 1994 Dec; 4(6):873-84. PubMed ID: 7734850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectin ligands and tumor-associated carbohydrate structures: specificities of alpha 2,3-sialyltransferases in the assembly of 3'-sialyl-6-sialyl/sulfo Lewis a and x, 3'-sialyl-6'-sulfo Lewis x, and 3'-sialyl-6-sialyl/sulfo blood group T-hapten.
    Chandrasekaran EV; Jain RK; Larsen RD; Wlasichuk K; Matta KL
    Biochemistry; 1995 Mar; 34(9):2925-36. PubMed ID: 7534477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of tumor associated sialyl-T-glycopeptides and their immunogenicity.
    Komba S; Werdelin O; Jensen T; Meldal M
    J Pept Sci; 2000 Dec; 6(12):585-93. PubMed ID: 11192238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic glycopeptides for the development of tumour-selective vaccines.
    Kunz H
    J Pept Sci; 2003 Sep; 9(9):563-73. PubMed ID: 14552419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding studies of alpha-GalNAc-specific lectins to the alpha-GalNAc (Tn-antigen) form of porcine submaxillary mucin and its smaller fragments.
    Dam TK; Gerken TA; Cavada BS; Nascimento KS; Moura TR; Brewer CF
    J Biol Chem; 2007 Sep; 282(38):28256-63. PubMed ID: 17652089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple column synthesis of a library of T-cell stimulating Tn-antigenic glycopeptide analogues for the molecular characterization of T-cell-glycan specificity.
    Frische K; Meldal M; Werdelin O; Mouritsen S; Jensen T; Galli-Stampino L; Bock K
    J Pept Sci; 1996; 2(4):212-22. PubMed ID: 9231328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delineating binding modes of Gal/GalNAc and structural elements of the molecular recognition of tumor-associated mucin glycopeptides by the human macrophage galactose-type lectin.
    Marcelo F; Garcia-Martin F; Matsushita T; Sardinha J; Coelho H; Oude-Vrielink A; Koller C; André S; Cabrita EJ; Gabius HJ; Nishimura S; Jiménez-Barbero J; Cañada FJ
    Chemistry; 2014 Dec; 20(49):16147-55. PubMed ID: 25324212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomimetic synthesis of the tumor-associated (2,3)-sialyl-T antigen and its incorporation into glycopeptide antigens from the mucins MUC1 and MUC4.
    Dziadek S; Brocke C; Kunz H
    Chemistry; 2004 Sep; 10(17):4150-62. PubMed ID: 15352098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of mucins with the Tn or Sialyl Tn cancer antigens including MUC1 are due to GalNAc-GalNAc interactions.
    Haugstad KE; Hadjialirezaei S; Stokke BT; Brewer CF; Gerken TA; Burchell J; Picco G; Sletmoen M
    Glycobiology; 2016 Dec; 26(12):1338-1350. PubMed ID: 27282157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoenzymatic synthesis of a MUC1 glycopeptide carrying non-natural sialyl TF-beta O-glycan.
    Tanaka E; Nakahara Y; Kuroda Y; Takano Y; Kojima N; Hojo H; Nakahara Y
    Biosci Biotechnol Biochem; 2006 Oct; 70(10):2515-22. PubMed ID: 17031043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.
    Sewell R; Bäckström M; Dalziel M; Gschmeissner S; Karlsson H; Noll T; Gätgens J; Clausen H; Hansson GC; Burchell J; Taylor-Papadimitriou J
    J Biol Chem; 2006 Feb; 281(6):3586-94. PubMed ID: 16319059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells.
    Huang J; Byrd JC; Yoon WH; Kim YS
    Oncol Res; 1992; 4(11-12):507-15. PubMed ID: 1284381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase.
    Kuhns W; Rutz V; Paulsen H; Matta KL; Baker MA; Barner M; Granovsky M; Brockhausen I
    Glycoconj J; 1993 Oct; 10(5):381-94. PubMed ID: 8298305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of tumor-associated glycopeptide antigens for the development of tumor-selective vaccines.
    Dziadek S; Kunz H
    Chem Rec; 2004; 3(6):308-21. PubMed ID: 14991920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of tumor-associated glycopeptides by lectins: the peptide context modulates carbohydrate recognition.
    Madariaga D; Martínez-Sáez N; Somovilla VJ; Coelho H; Valero-González J; Castro-López J; Asensio JL; Jiménez-Barbero J; Busto JH; Avenoza A; Marcelo F; Hurtado-Guerrero R; Corzana F; Peregrina JM
    ACS Chem Biol; 2015 Mar; 10(3):747-56. PubMed ID: 25457745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.